SHSE:688576 (China)
Â
Ordinary Shares - Class A
Â¥
61.48
(-0.87%)
Jul 16
Business Description
Chongqing Xishan Science and Technology Co Ltd
Share Class Description:
SHSE:688576: Ordinary Shares - Class ACompare
Compare
Traded in other countries / regions
688576.China IPO Date
2023-06-06Description
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 755.13 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 703.14 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 18.99 | |||||
| Beneish M-Score | 16.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.8 | |||||
| 3-Year EBITDA Growth Rate | 64.6 | |||||
| 3-Year EPS without NRI Growth Rate | 60.1 | |||||
| 3-Year Book Growth Rate | 141.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.64 | |||||
| 9-Day RSI | 53.88 | |||||
| 14-Day RSI | 50.72 | |||||
| 6-1 Month Momentum % | -35.14 | |||||
| 12-1 Month Momentum % | -52.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.23 | |||||
| Quick Ratio | 14.64 | |||||
| Cash Ratio | 13.65 | |||||
| Days Inventory | 205.96 | |||||
| Days Sales Outstanding | 29.16 | |||||
| Days Payable | 222.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.2 | |||||
| Shareholder Yield % | 0.1 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.95 | |||||
| Operating Margin % | 30.24 | |||||
| Net Margin % | 32.46 | |||||
| FCF Margin % | -27.98 | |||||
| ROE % | 6.69 | |||||
| ROA % | 6.3 | |||||
| ROIC % | 26.67 | |||||
| ROC (Joel Greenblatt) % | 72.48 | |||||
| ROCE % | 7.48 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.4 | |||||
| PE Ratio without NRI | 25.96 | |||||
| PS Ratio | 8.25 | |||||
| PB Ratio | 1.53 | |||||
| Price-to-Tangible-Book | 1.55 | |||||
| Price-to-Operating-Cash-Flow | 128.88 | |||||
| EV-to-EBIT | 13.79 | |||||
| EV-to-EBITDA | 13.75 | |||||
| EV-to-Revenue | 5.02 | |||||
| EV-to-FCF | -18.63 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Price-to-Net-Current-Asset-Value | 2.18 | |||||
| Price-to-Net-Cash | 2.45 | |||||
| Earnings Yield (Greenblatt) % | 7.25 | |||||
| FCF Yield % | -3.16 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers